Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.

By H. Buchwald, R. Estok, K. Fahrbach, Deirdre K Banel, M. Jensen, W. Pories, J. Bantle, I. Sledge. American Journal of Medicine, 2009

2,569 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/56c3f1a337ddc5fbdca08fb36d83ccd685f305db

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. V. Basevi
2. S. Grundy

In Endocrinology, Diabetes and Metabolism

1. S. Grundy
2. R. Bergenstal
3. V. Basevi
4. C. Apovian

In Surgery

1. V. Basevi
2. S. Grundy

Citations in the corpus

• Pharmacological management of obesity: an endocrine Society clinical practice guideline. (2015, positive): “T2DM Yes Cohen, 2012 (132); Mingrone, 2012 (133); Schauer, 2012 (134); Buchwald, 2009 (135) Hypertension Yes Ilane-Parikka, 2008 (136); Phelan, 2007 (137); Zanella, 2006 (138) Dyslipidemia and metabolic syndrome Yes Ilane-Parikka, 2008 (136); Phelan, 2007 (137); Zanella, 2006 (138) Cardiovascular di”
• Standards of Medical Care in Diabetes—2012 (2011, background): “A meta-analysis of studies of bariatric surgery involving 3,188 patients with diabetes reported that 78% had remission of diabetes (normalization of blood glucose levels in the absence of medications), and that the remission rates were sustained in studies that had follow-up exceeding 2 years (203).”
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2012, background): “The majority of patients are able to stop some, or even all, of their anti-hyperglycaemic medications, although the durability of this effect is not known [105].”
• Diabetes and Cancer (2010, neutral): “Bariatric surgery is a very effective treatment for type 2 diabetes, with a metaanalysis showing that type 2 diabetes resolved in 78% and resolved or improved in 87% of patients after bariatric surgery (27).”
• Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss (2010, background): “Unraveling the immediate and long-term adaptations associated with gastric bypass surgery has proved challenging predominantly because the consequences of this procedure include caloric restriction, diminished nutrient absorption, reduced adipose mass, modified gut hormone signaling, and changes in ”
• Standards of Medical Care in Diabetes—2013 (2012, background): “A meta-analysis of studies of bariatric surgery involving 3,188 patients with diabetes reported that 78% had remission of diabetes (normalization of blood glucose levels in the absence of medications) and that the remission rates were sustained in studies that had followup exceeding 2 years (233).”
• Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial (2018, background): “Overall,malabsorptive biliopancreatic diversionhas been shown tobe the most efficient operation in termsof type 2diabetes remission rates (but the most radical in terms of potentially severe adverseeffects), followedbyRoux-en-Ygastricbypass, sleevegastrectomy, and gastric banding.(24) However, when ”